Loading...
Targeting the glucocorticoid receptor signature gene Mono Amine Oxidase-A enhances the efficacy of chemo- and anti-androgen therapy in advanced prostate cancer
Despite increasing options for treatment of castration-resistant prostate cancer, development of drug resistance is inevitable. The glucocorticoid receptor (GR) is a prime suspect for acquired therapy resistance, as prostate cancer (PCa) cells are able to increase GR signaling during anti-androgen t...
Saved in:
| Published in: | Oncogene |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Nature Publishing Group UK
2021
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8084733/ https://ncbi.nlm.nih.gov/pubmed/33795839 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41388-021-01754-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|